News & Trends - Pharmaceuticals
Medicines Australia says new Strategic Agreement not to be finalised until after the Budget
Pharma News: Delivering timely access to much-needed vaccines and innovative treatments for Australians is a priority for the Government, Medicines Australia, Industry and patients.
Medicines Australia has been working closely with the Minister and his Department since last year to develop a new 5-year Strategic Agreement to commence at the expiry of the current Agreement in July 2022, to deliver greater long-term certainty for both industry and Government.
Medicines Australia has mutually agreed to continue discussions after the Budget to provide additional time for important but complex elements to be considered and finalised, as soon as possible.
Medicines Australia’s partnership with Government led to the announcement in October 2020 of the removal of the offset policy and the establishment New Medicines Funding Guarantee which will deliver new funding each year for the listing of the new medicines on the PBS, with approximately $2.8 billion in new funding expected to be committed over the next four years.
“We look forward to seeing the dividend of the New Medicines Funding Guarantee in next week’s Budget papers which will outline the investment in new PBS medicines listings since the last economic statement from Government,” Medicines Australia said in a statement.
“The Government and Industry’s immediate focus must remain the Covid-19 response and vaccine roll-out. Following next week’s Budget, we will work to finalise commitments in the new Agreement that prioritise tangible benefits for patients.
“We look forward to agreeing further significant improvements in patient access to medicines and in particular, commitments to modernise Health Technology Assessment to keep pace with scientific breakthroughs and rapid advancements in medicines and technologies.”
Medicines Australia will continue to work with Government to deliver an Agreement that will meet the Australian community’s expectations and ensure that patients will be able to access new medicines and therapies when they need them.
Digital & Innovation
Medical drone to reduce health equity gaps in rural and remote Australia
A specialised medical drone which increases accessibility to essential health services such as pathology, medicines, and telehealth services in rural […]
MoreNews & Trends - Pharmaceuticals
We’ve spent more on healthcare, but it’s been worth it
Healthcare expenditure is surging, with Australia now allocating approximately one-tenth of its budget to this sector. This financial uptick prompts […]
MoreNews & Trends - Pharmaceuticals
New partnership to raise the bar in precision oncology in Queensland
Pharma News: The Australian Translational Genomics Centre (ATGC) is teaming up with non-profit research organisation Omico and the PrOSPeCT program […]
MoreNews & Trends - Biotechnology
AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm
Biotech News: AusBiotech, the nation’s leading industry body for the biotech sector, has named former leader at Sanofi, Rebekah Cassidy, […]
More